Skip to main content

Blood Glucose Monitoring System Market Size to Surpass USD 32.99 billion by 2030, exhibiting a CAGR of 9.9%

As per the report by Fortune Business Insights, the global Blood Glucose Monitoring System Market size is projected to reach USD 32.99 billion by 2030, at a CAGR of 9.9% during the forecast period

Pune, India, May 29, 2023 (GLOBE NEWSWIRE) — The Global Blood Glucose Monitoring System Market size is anticipated to rise during the forecast period due to the increasing prevalence of diabetes and technological development in medical equipment. According to Fortune Business Insights, the global blood glucose monitoring system market size was valued at USD 15.80 billion in 2022 and is projected to grow from USD 17.03 billion in 2023 to USD 32.99 billion by 2030, exhibiting a CAGR of 5.1% during the forecast period.

Key Industry Development:

  • March 2023: With automated insulin delivery systems, Abbott received the U.S. FDA approval for its FreeStyle Libre 3 and FreeStyle Libre 2 integrated CGM sensors.


Request a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/sample/blood-glucose-monitoring-market-100648


Key Takeaways

  • The rising prevalence of diabetes wounds and the introduction of advanced products for monitoring blood glucose levels are the key drivers of the market.
  • F. Hoffmann-La Roche Ltd., Abbott, and Dexcom, Inc. are the top players in the market.
  • The market will exhibit steady growth at a CAGR of 9.9% during the forecast period (2023-2030).
  • The global market stood at US$ 15.80 Bn in 2022 and is projected to reach USD 32.99 billion by 2030.

Discover the Leading Players Featured in the Report:

Abbott (U.S.),    B. Braun Melsungen AG (Germany), Dexcom, Inc. (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), Medtronic (Ireland), F. Hoffmann-La Roche Ltd (Switzerland), Terumo Corporation (Japan), LifeScan IP Holdings, LLC (U.S.), Senseonics (U.S.)

Report Scope & Segmentation

Report CoverageDetails
Forecast Period2023 to 2030
Forecast Period 2023 to 2030 CAGR9.9%
2030 Value ProjectionUSD 32.99 billion
Base Year2022
Blood Glucose Monitoring System Market Size in 2023USD 17.03 billion
Historical Data for2019 to 2021
No. of Pages222



Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/blood-glucose-monitoring-market-100648


Drivers & Restraints:

Increasing Prevalence of Diabetes to Bolster Market Growth

The Blood Glucose Monitoring System market is expected to witness significant growth during the forecast period due to the increasing prevalence of diabetes. Also, the rising diagnosis rate before conducting various surgeries is anticipated to fuel the market growth. Furthermore, developing urbanization and an increasing shift toward a sedentary lifestyle will stimulate the demand for monitoring systems in the coming years.

According to the International Diabetes Federation 2021, it was projected that around 537 million adults were suffering from diabetes in countries such as India, China, the U.S., Mexico, and Brazil, which accounted for an estimated 51.6% of the global diabetes population in 2021.

However, lower diagnosis and treatment rates in emerging countries may hinder market growth. 

Segments:

By Device Type

  • Continuous Glucose Monitoring Systems
  • Self-Monitoring Blood Glucose Systems

By Type

  • Non-invasive
  • Invasive

By Modality

  • Wearable
  • Non-wearable

By Patient Type

  • Type-1 Diabetes
  • Type-2 Diabetes

By Distribution Channel

  • Institutional Sales
  • Retail Sales

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World


Quick Buy – Blood Glucose Monitoring System Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100648


Report Coverage:

The report focuses on providing factual information regarding market development and recent trends. Major strategies adopted by key market players such as mergers, partnerships, acquisitions, and alliances are elaborated further. Also, drivers and restraints affecting market growth are highlighted further in this report. Also, regional information and a list of key market players in the segmented region are given in this report.


Regional Insights:

North America Holds Highest Market Share Due to Emerging Technologies

North America dominates the global Blood Glucose Monitoring System market share due to the increasing number of diabetes patients and rising adoption of technologically advanced medical devices. The regional market stood at USD 6.92 billion in 2022 and is projected to grow at a fast pace during the forecast period.

Europe is expected to hold the second-highest global market share during the projected period. The regional market growth is attributed to increasing awareness regarding diabetes management and self-monitoring systems.  

Competitive Landscape:

Key Players Focus on Partnerships to Expand their Business Globally 

The key Blood Glucose Monitoring System players focus on partnering with supporting organizations to expand their business globally. Also, developing and designing a new product range allows key players to enhance their product portfolio.


To Get This Report Customized, Visit: https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/blood-glucose-monitoring-market-100648


FAQ’s

How big is the Blood Glucose Monitoring System Market?

The blood Glucose Monitoring System Market size was USD 17.03 billion in 2023.

How fast is the Blood Glucose Monitoring System Market growing?

The Blood Glucose Monitoring System Market will exhibit a CAGR of 9.9% during the forecast period, 2023-2030


Related Reports:

Blood Glucose Meter Market Share, Size, Trends and Forecast 2023-2030

U.S. Blood Glucose Monitoring System Market Size, Share, Trends, Growth | Global Forecast Report 2026

Non-Invasive Blood Glucose Monitoring Market Size, Share, Trends, Growth 2023-2030

Remote Patient Monitoring Devices Market Trends, Growth 2023-2028


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.